SMAD3 and neoplasm: CHLD has been found to regulate the expression of proteins Smad3 and Smad7 in the TGF-β1/Smad pathway to inhibit tumor proliferation in tumor-bearing mice with renal cell carcinoma (Pan et al., 2023).